









|
| @ŠÖ“Œ˜A‡ŽY‰È•wl‰ÈŠw‰ï‰ïŽ ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ[ƒiƒ‹ |
<< Šw‰ïނ֖߂é
<< ‘O‚̃y[ƒW‚Ö–ß‚é
‘æ90‰ñŠwpW‰ïi•½¬7”N9ŒŽ17“új
yˆê”ʉ‰‘èz
—‘‘ƒŽîá‡iIIIj —‘‘ƒclear cell carcinoma‚Ì—Õ°“IŒŸ“¢
Ίª@Ñã, ‹e’n@ˆ¤Žq, Š`–Ø@¬Žq, ¬ô@’¼”ü, –@³ƒ, ˆäŒû@“o”üŽq, •“c@‰À•F
“Œ‹ž—Žqˆã‰È‘åŠwŽY•wl‰È
“ú–{ŽY‰È•wl‰ÈŠw‰ïŠÖ“Œ˜A‡’n•û•”‰ï‰ï•ñ, 32(4)
464-464, 1995
|